Srikrishin Rohra in Concord, California

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1981
The Primary Medical Specialty for Srikrishin Rohra is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 43
PAC (PECOS ID)#: 6507948304
NPI #: 1811979727
NPI Created On: 11/16/2005
NPI Last Updated Listed as: 09/12/2014
Primary Taxonomy Code: 207RC0000X
License Number:
A50848
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana

They are listed as accepting new patients.

Languages spoken by staff include: English, Sindhi, Hindi.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
7. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
8. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
9. Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days
10. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
11. Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
12. Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
13. New patient office or other outpatient visit, typically 45 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Initial hospital inpatient care, typically 70 minutes per day
16. Subsequent hospital inpatient care, typically 35 minutes per day
17. Technetium tc-99m sestamibi, diagnostic, per study dose
18. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec
19. Injection, regadenoson, 0.1 mg